For the Inventor, By the Inventor

Enter assignee name

Druggability Technologies IP Holdco Limited

USPTO Granted Patents = 10

% Expired Patents = 70.0

EPO Patents = 2

Forward Citations = 8

Loading Chart...

Loading Chart...

14 inventors (with patents filed for the assignee):

Hristos Glavinas (10 out of 16 patents)

Genovéva Filipcsei (10 out of 14 patents)

Richárd Balázs Kárpáti (7 out of 11 patents)

4. Tamás Jordán (7 out of 10 patents)

5. Orsolya Basa-Dénes (7 out of 10 patents)

6. Tamás Solymosi (6 out of 11 patents)

7. Erzsébet Réka Angi (5 out of 7 patents)

8. Gergo Patyi (5 out of 7 patents)

9. Zsolt Ötvös (5 out of 9 patents)

10. Betti Szabóné Ordasi (3 out of 3 patents)

11. László Molnár (2 out of 3 patents)

12. Réka Angi (2 out of 3 patents)

13. Nikoletta Erdősi (2 out of 2 patents)

14. Andrea Ujhelyi (1 out of 3 patents)

15. Gábor Heltovics (1 patent)

10 patents: Sort by Forward Citations

1. 10507214 - Pharmaceutical composition containing celecoxib (2019-12-17),

2. 10500202 - Pharmaceutical formulation containing tadalafil (2019-12-10),

3. 10383865 - Pharmaceutical combination composition comprising complex formulations of Ivacaftor and Lumacaftor and their salts and derivatives, process for their preparation thereof and pharmaceutical compositions containing them (2019-08-20),

4. 10376501 - Complexes of lumacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2019-08-13),

5. 10307429 - Complexes of celecoxib and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2019-06-04),

6. 10206915 - Complexes of Ivacaftor and its salts and derivatives, process for the preparation thereof and pharmaceutical compositions containing them (2019-02-19),

7. 10130582 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2018-11-20),

8. 10080762 - Pharmaceutical composition containing Celecoxib (2018-09-25),

9. 9623034 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2017-04-18),

10. 9592244 - Complexes of abiraterone acetate, process for the preparation thereof and pharmaceutical compositions containing them (2017-03-14),

Company Overview

Druggability Technologies IP Holdco Limited is a biotechnology firm based in Msida, Malta, specializing in the development of innovative drug discovery technologies. The company focuses on enhancing the drug development process through advanced methodologies that assess the druggability of various compounds. By leveraging cutting-edge research in pharmacology and molecular biology, Druggability Technologies aims to streamline the transition from laboratory research to clinical applications, ultimately improving therapeutic outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#2 in Msida

#19 in Malta

#56,047 in the World

Druggability Technologies IP Holdco Limited

Forward Citations = 8

14 inventors:

Hristos Glavinas (10 out of 16 patents)

Genovéva Filipcsei (10 out of 14 patents)

Richárd Balázs Kárpáti (7 out of 11 patents)

4. Tamás Jordán (7 out of 10 patents)

5. Orsolya Basa-Dénes (7 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Druggability Technologies IP Holdco Limited. Retrieved from https://idiyas.com/company/druggability-technologies-ip-holdco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…